Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1996
10/03/1996WO1996030028A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
10/03/1996WO1996030021A1 Azathioprine compositions for colonic administration
10/03/1996WO1996030020A1 Transdermal device for the delivery of alfuzosin
10/03/1996WO1996030011A1 Topical antimycotic compositions
10/03/1996WO1996030001A1 Method of making a pressure sensitive skin adhesive sheet material
10/03/1996WO1996030000A1 Pharmaceutical composition for transdermic delivery
10/03/1996WO1996029995A1 Oral 2-methyl-thieno-benzodiazepine formulation
10/03/1996WO1996029992A1 Diltiazem controlled release formulation
10/03/1996WO1996029991A1 Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same
10/03/1996WO1996029989A1 Stable protein:phospholipid compositions and methods____________
10/03/1996WO1996029988A1 Topical formulation for local delivery of a pharmaceutically active agent
10/03/1996WO1996029987A1 Reduction of adhesions using controlled delivery of active oxygen inhibitors
10/03/1996WO1996029984A1 Sterile ophthalmological gel preparation applicable in drops and process for producing it
10/03/1996WO1996029975A1 Oil/water mixture composition
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates
10/03/1996CA2805588A1 Vascular endothelial cell growth factor antagonists
10/03/1996CA2770491A1 Hapten-carrier conjegates for use in drug-abuse therapy
10/03/1996CA2588767A1 Hapten-carrier conjugates for use in drug-abuse therapy
10/03/1996CA2216728A1 Azathioprine compositions for colonic administration
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2215256A1 Transdermal device for the delivery of alfuzosin
10/02/1996EP0734721A2 Method of incorporating drugs into a polymer component of stents
10/02/1996EP0734720A1 Particles based on polyamino-acid(s) for use as carriers for active agents and their processes of preparation
10/02/1996EP0734371A1 Novel retinoid conjugate compounds and methods for treating skin aging
10/02/1996EP0734267A1 Aqueous topical compositions
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996EP0734257A1 Pharmaceutical compositions for topical use containing (s)-2-(4-isobutylphenyl)propionic acid
10/02/1996EP0734251A1 Method of transmitting a biologically active material to a cell
10/02/1996EP0734250A1 Lipid vesicles containing avocado oil unsaponifiables
10/02/1996EP0734247A1 Cosmetic and/or pharmaceutical preparations
10/02/1996EP0734209A1 Growth promoting composition for fish
10/02/1996EP0653943A4 Targeting somatic gene therapy to joints.
10/02/1996EP0489181B1 Solid preparation
10/02/1996EP0485578B1 Neurotropic growth factors comprising a homeobox peptide
10/02/1996EP0480054B1 Percutaneously absorbable composition of morphine hydrochloride
10/02/1996EP0450094B1 Hydrophilic polymer-silicate mineral composite and its use
10/02/1996DE19511322A1 Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung Sterile ophthalmic gels containing medium chain triglycerides and processes for their preparation
10/02/1996CN1132479A Mycophenolate mofetil high dose oral suspensions
10/02/1996CN1132478A A novel pharmaceutical for oral administration comprising progresterone and a polyethyelene glycol together with an exipient
10/02/1996CN1032901C 5,10-methylentetrahydrofolic acid-cyclodextrin inclusion compounds
10/02/1996CN1032900C Method for prep. of locally-used metrohidazole formulations
10/01/1996US5561166 Urea/lactate topical compositions for dry skin
10/01/1996US5561159 Topical applying to face
10/01/1996US5561158 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
10/01/1996US5561157 Method for enhancing the therapeutic effect of a composition comprising hydroquinone and comprising same
10/01/1996US5561156 Method of treating wrinkles using methyllactic acid
10/01/1996US5561155 Method of treating wrinkles using galacturonic acid or galacturonolactone
10/01/1996US5561154 Muscle relaxants
10/01/1996US5561153 Method of treating wrinkles using mucic acid or mucolactone
10/01/1996US5561121 Antitumor alkylating agent
10/01/1996US5561116 Solid product containing propolis components, and preparation and uses thereof
10/01/1996US5561043 Genetic engineering
10/01/1996US5560933 Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
10/01/1996US5560929 Structured copolymers and their use as absorbents, gels and carriers of metal ions
10/01/1996US5560923 Method of encapsulating anthracycline in liposomes
10/01/1996US5560921 AMINOPHENYLALKANOL VASOCONSTRICTOR COMPLEXED WITH POLYMERIC POLYCARBOXYLATE; the amine group in pseudoephedrine, phenylephrine or a phenylpropanolamine interacts with acid group in methacrylic acid-methyl methacrylate copolymer (Eudragit); dosage form for fast release
10/01/1996US5560913 Pharmaceutical compositions
10/01/1996US5560910 Topical anti-inflammatory composition and method
10/01/1996US5560902 Microfluidization of radioactive calcium/oxyanion-containing particles
10/01/1996CA2033499C Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
10/01/1996CA2004468C Sustained release, comfort formulation for glaucoma therapy
10/01/1996CA1338619C Lectin complex and method and probe for making same
09/1996
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996029342A1 Lipophilic peptide hormone derivatives
09/26/1996WO1996029103A1 Method of manufacturing and storing solutions
09/26/1996WO1996029096A1 Gene transfer preparation
09/26/1996WO1996029095A1 Hcg liquid formulations
09/26/1996WO1996029094A1 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
09/26/1996WO1996029087A1 Methods for reduced renal uptake of antibody fragments
09/26/1996WO1996029080A1 Poly(hydroxy acid)/polymer conjugates for skin applications
09/26/1996WO1996029070A1 Extended stability formulations for paclitaxel
09/26/1996WO1996029064A1 Oil in water emulsions containing propofol and edetate
09/26/1996WO1996029060A1 Long-shelf-life medicaments
09/26/1996WO1996029059A1 Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses
09/26/1996WO1996029058A1 Peroral composition for controlled release in the lower gastrointestinal tract
09/26/1996WO1996029057A1 Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
09/26/1996WO1996029053A1 Transparent rapid-release preparations of non-steroid analgesics
09/26/1996WO1996024364A3 Antimicrobial composition composed of controlled release glasses
09/26/1996WO1996023071A3 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
09/26/1996DE19509806A1 Lagerstabile Arzneiformen Storage-stable dosage forms
09/26/1996DE19509805A1 Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica Transparent, quick-release formulations of nonsteroidal analgesics
09/26/1996CA2215936A1 Hcg liquid formulations
09/26/1996CA2215825A1 Stem-loop and circular oligonucleotides
09/26/1996CA2215739A1 Lipophilic peptide hormone derivatives
09/26/1996CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996CA2214246A1 Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
09/26/1996CA2213747A1 Peroral composition for controlled release in the lower gastrointestinal tract
09/26/1996CA2213720A1 Storage-stable drug forms
09/26/1996CA2190451A1 Method of manufacturing and storing solutions
09/25/1996EP0733702A1 Stable transglutaminase preparations and process for their preparation
09/25/1996EP0733644A1 Glucagon-like insulinotropic complexes, compositions and methods
09/25/1996EP0733372A2 Pharmaceutical base for the formulation of nanosuspensions
09/25/1996EP0733367A1 Oral olanzapine formulation
09/25/1996EP0733358A2 Nanosuspensions for intravenous application
09/25/1996EP0733357A1 Pharmaceutical formulations in form of thixotropic gel
09/25/1996EP0733106A1 Plant arabinogalactan protein (agp) genes
09/25/1996EP0733072A1 Antibody against carcinoembryonic antigen (cea)
09/25/1996EP0733067A1 N-terminally chemically modified protein compositions and methods
09/25/1996EP0733066A1 Pretargeting methods and compounds
1 ... 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 ... 1712